OBJECTIVE-Vitamin
nvironmental factors influence the presentation of type 1 diabetes in humans and in animal models. Like many autoimmune diseases, type 1 diabetes is less frequent in regions close to the equator (1) . An obvious candidate to explain this difference is sunlight exposure and resulting vitamin D status.
Experimental, clinical and epidemiological data show that maintenance of an optimal vitamin D status is fundamental for proper calcium absorption and bone mineralization and is also critical for avoidance of a variety of diseases, such as tuberculosis (2) , but vitamin D insufficiency and rickets are reemerging (3) . A Finnish study revealed that children with suspected rickets during the first year of life have an increased frequency of type 1 diabetes compared with children without vitamin D deficiency (4) . In parallel, we and others demonstrated that vitamin D-deficient NOD mice have a more aggressive disease (5, 6) , as reflected by earlier onset and doubled disease incidence, whereas high doses of active vitamin D, 1,25-dihydroxyvitamin D 3 [1, 25 (OH) 2 D 3 ], prevent insulitis and diabetes in NOD mice (7, 8) .
Immune changes induced by 1,25(OH) 2 D 3 include modulation of phenotype and function of dendritic cells, restoration of regulatory T cells, and improved elimination of autoimmune effector cells (9) . 1,25(OH) 2 D 3 acts via the vitamin D receptor (VDR), which belongs to the steroid hormone receptor superfamily. As VDR is expressed in ␤-cells and in most immune cells, it is not surprising that the 1,25(OH) 2 D 3 -VDR complex modulates insulin secretion, cell differentiation, and innate and adaptive immune functions. Moreover, associations between some VDR polymorphisms and type 1 diabetes have been described in several populations (10, 11) . In view of these data, we investigated the role of the VDR gene in autoimmune diabetes development by generating and studying a congenic stock of NOD mice with a disruption of the VDR gene.
RESEARCH DESIGN AND METHODS
The original Vdr tm1Ska /Vdr tm1Ska (VDR Ϫ/Ϫ ) mice were produced by Dr. S. Kato (University of Tokyo, Tokyo, Japan) and were kept on C57BL/6 ϫ CBA background (12) . After backcrossing male VDR Ϫ/ϩ heterozygotes to female NOD mice (N10 and N14), VDR Ϫ/ϩ NOD mice were intercrossed to produce experimental animals of three genotypes. Genotypes of mice from N2 to N14 generation were determined by testing tail DNA with microsatellite markers linked to 15 insulin-dependent diabetes loci (Idd1-Idd15), as previously described (13) .
All experiments were performed on age-and sex-matched VDR Ϫ/Ϫ and VDR ϩ/ϩ NOD littermates from intercrosses of N10 and N14 generations. Complete methods, including a description of the procedures for all in vitro immune phenotyping, assessment of diabetes, pancreatic histopathology with insulitis scoring and insulin content determination, calcium and bone parameters, RNA isolation, and quantitative RT-PCR analysis are provided in an online appendix (available at http://dx.doi.org/10.2337/db07-1095).
Data were analyzed using NCSS 2000 statistical software (Kaysville, UT). Results are expressed as means Ϯ SEM, and differences are considered significant when P Յ 0.05. Differences between groups were evaluated by ANOVA and post hoc unpaired Student's t test. For comparing the in vivo insulitis and diabetes incidence, Kaplan-Meier survival curves, the log-rank test, and the 2 test were used.
RESULTS
Vitamin D-resistant phenotype of VDR ؊/؊ NOD mice. VDR Ϫ/Ϫ NOD mice exhibited alopecia and growth retardation. As expected, VDR was undetectable, whereas CYP27B1 was overinduced and CYP24A1 was inhibited in VDR Ϫ/Ϫ NOD kidneys (online appendix Fig. 1A-C) . Also, calbindin-D 9k was reduced in VDR Ϫ/Ϫ NOD kidneys (online appendix Fig. 1D ). VDR Ϫ/Ϫ NOD mice showed anticipated abnormalities in mineral homeostasis including hypocalcemia (Fig. 1B) . VDR Ϫ/Ϫ NOD mice displayed abnormally high levels of 1,25(OH) 2 D 3 and low 25(OH)D 3 ( Fig. 1C-D) . These metabolic imbalances resulted in typical skeletal defects, including hypocalcemia (Fig. 1E) , decreased bone mineral density (Fig. 1F-G) , widened growth plates with hypomineralization, less trabeculae, and thicker osteoid seams (data not shown).
Effect of VDR deficiency on T-lymphocytes in NOD mice. VDR
Ϫ/Ϫ NOD mice had less immature CD4 Ϫ CD8 Ϫ T-cells expressing the T-cell receptor-␣/␤ in the periphery and fewer regulatory CD4 ϩ CD25 ϩ T-cells in spleen and mesenteric lymph nodes and, to a lesser extent, in thymus (Table 1) . VDR Ϫ/Ϫ NOD splenocytes displayed equal responses to anti-CD3 compared with VDR ϩ/ϩ NOD splenocytes (male, 14 Ϯ 3 vs. 14 Ϯ 1 stimulation index [SI], respectively, P ϭ NS; female, 17 Ϯ 5 vs. 16 Ϯ 3 SI, P ϭ NS). Percentage of activation-induced cell death was not altered in VDR Ϫ/Ϫ vs. VDR ϩ/ϩ NOD mice (male, 32 Ϯ 5 vs. 34 Ϯ 1%, respectively, P ϭ NS; female, 37 Ϯ 6 vs. 39 Ϯ 5%, P ϭ NS). Effect of VDR deficiency on gene expression and nuclear factor-B activation of NOD macrophages after lipopolysaccharide stimulation. Disruption of VDR in NOD mice did not induce significant changes in number (Table 1) or function (chemotaxis, phagocytosis, and respiratory burst capacity) of CD11b ϩ myeloid cells (data not shown). As expected, VDR was undetectable in VDR Ϫ/Ϫ NOD macrophages, while lipopolysaccharide (LPS) upregulated VDR in VDR ϩ/ϩ NOD macrophages ( Fig. 2A) . Comparably low levels of CYP27B1 were present in macrophages of both types of NOD mice (Fig. 2B ). Basal expression of interleukin (IL)-1, IL-6, and CC chemokine ligand 2 (CCL2) was lower in VDR Ϫ/Ϫ NOD macrophages, while toll-like receptor 4 ligation amplified IL-1, IL-6, and CCL2 expression in VDR Ϫ/Ϫ NOD macrophages (though the effect was less pronounced than in VDR ϩ/ϩ NOD macrophages) (Fig. 2C-E) . In contrast to VDR ϩ/ϩ NOD macrophages, no induction of CAMP (cathelicidan antimicrobial peptide) transcripts upon LPS stimulation was observed in VDR Ϫ/Ϫ NOD macrophages (Fig. 2F ). In unstimulated macrophages from VDR Ϫ/Ϫ and VDR ϩ/ϩ NOD mice, p65 nuclear factor-B (NF-B) was mainly located in cytoplasm. In response to LPS, translocation of p65 to the nucleus was significantly less pronounced in VDR Ϫ/Ϫ NOD macrophages (Fig. 2G) . Effect of VDR deficiency on dendritic cell phenotype. Ablation of VDR in NOD mice did not alter numbers of CD11c ϩ dendritic cells in central and peripheral immune organs (Table 1) . Nevertheless, thymic and lymph node dendritic cells from VDR Ϫ/Ϫ NOD mice showed defective differentiation into mature dendritic cells as indicated by an even lower CD86 expression (online appendix Fig. 2A) .
Different results were observed in dendritic cells obtained in vitro from bone marrow cell cultures. Although percentage of CD11c ϩ dendritic cells was similar for VDR Ϫ/Ϫ and VDR ϩ/ϩ NOD mice (data not shown), expression of major histocompatibility complex II and CD86 molecules was higher on bone marrow-derived dendritic cells from VDR Ϫ/Ϫ NOD mice relative to VDR ϩ/ϩ NOD mice (online appendix Fig. 2B ). Effect of VDR deficiency on insulitis and diabetes incidence of NOD mice. VDR Ϫ/Ϫ NOD mice had normal islet architecture and developed insulitis with similar severity as VDR ϩ/ϩ NOD littermates (Fig. 3A) . In N10 generation, diabetes development by the age of 250 days was similar between VDR Ϫ/Ϫ and VDR ϩ/ϩ NOD littermates in final outcome (male, 50 vs. 50%, respectively, P ϭ NS; female, 67 vs. 80%, P ϭ NS) and in disease onset (male, 87 Ϯ 2 vs. 113 Ϯ 38 days, P ϭ NS; female, 129 Ϯ 30 vs. 111 Ϯ 24 days, P ϭ NS). In N14 generation, diabetes incidence in VDR Ϫ/Ϫ NOD males and females was 30 and 69%, respectively, while 38% of the VDR ϩ/ϩ NOD males and 70% of the VDR ϩ/ϩ NOD females became diabetic by 250 days (NS) (Fig. 3B) . Timing of disease onset was similar in VDR Ϫ/Ϫ and VDR ϩ/ϩ NOD littermates (male, 163 Ϯ 7 vs. 166 Ϯ 10 days, respectively, P ϭ NS; female, 142 Ϯ 18 vs. 139 Ϯ 13 days, P ϭ NS).
Glucose tolerance tests in VDR Ϫ/Ϫ and VDR ϩ/ϩ NOD mice were identical as indicated by areas under the curve (AUC) (male, 29,928 Ϯ 5,807 vs. 21,998 Ϯ 2,123 AUC, respectively, P ϭ NS; female, 23,409 Ϯ 711 vs. 21147 Ϯ 2,973 AUC, P ϭ NS).
DISCUSSION
Vitamin D deficiency in early life leads to a doubling in diabetes incidence in later life in NOD mice (5) and is associated with a higher risk for type 1 diabetes in humans (4). To date, only one receptor for the active form of vitamin D has been identified; it was therefore surprising to find that introduction of the VDR Ϫ/Ϫ phenotype onto the NOD background did not alter insulitis or diabetes presentation in NOD mice. These findings are in contrast to the more severe and accelerated diabetes in vitamin D-deficient NOD mice (5) .
This discrepancy in disease phenotype between absence of ligand and absence of receptor is also described for other members of the nuclear receptor superfamily, e.g., the thyroid hormone receptor-␣/␤. The hypothyroid state results in severe abnormalities in cerebral cortical, cerebellar, and ear development, whereas normal central nervous system structure and function, apart from deafness caused by an inner ear defect, are observed in thyroid hormone receptor-␤ Ϫ/Ϫ mice (14) . These data emphasize that nuclear receptors play independent roles even in the absence of an agonistic ligand.
This difference between loss of ligand and loss of receptor is not homogenous for different tissues. For the VDR, this discrepancy has already been reported for hair growth (15) . VDR Ϫ/Ϫ mice and humans with VDR mutations develop alopecia, whereas vitamin D-deficient mice or humans have normal hair cycles.
Also, in the immune system, differences between loss of ligand and loss of receptor are found. Vitamin D-deficient animals and humans have an increased sensitivity to mycobacteria (2), probably related to deficient macrophage function, whereas macrophage function was normal in VDR Ϫ/Ϫ NOD mice. On the other hand, aberrances in dendritic cell phenotype were observed here and previously in VDR Ϫ/Ϫ mice (16), whereas dendritic cells from vitamin D-deficient mice do not present abnormalities (E. van Etten, unpublished observations). These changes in dendritic cells may contribute to the changes in T-lymphocyte subsets observed in VDR Ϫ/Ϫ NOD mice but not in vitamin D-deficient mice.
Absence of ligand and absence of a nuclear receptor also affect disease presentation differently. Experimental autoimmune encephalomyelitis incidence was de- creased in VDR Ϫ/Ϫ mice (17), whereas vitamin D deficiency induced acceleration of disease (18) . In contrast, in models of inflammatory bowel disease, more severe colitis was present in the absence of either vitamin D or its receptor (19) . A clear explanation for these diverse disease phenotypes is lacking, but involvement of different immune cells in respective target organs that are affected in a different way by ligand or receptor loss may be responsible.
A remarkable finding here was that VDR Ϫ/Ϫ NOD mice had severe immune defects considered crucial for diabetes development in NOD mice, whereas VDR Ϫ/Ϫ NOD mice did not display an enhanced susceptibility to disease. For instance, less T-cell receptor-␣/␤ ϩ CD4 Ϫ CD8 Ϫ T-cells and regulatory CD4
ϩ CD25 ϩ T-cells were present in VDR Ϫ/Ϫ NOD immune organs, postulated to contribute to an inability to maintain peripheral tolerance and, hence, diabetes development in NOD mice (20, 21) . Moreover, inactivation of VDR in NOD mice resulted in disturbed cytokine and chemokine profile with extremely low IL-1, IL-6, and CCL2 transcripts, implicated in aberrant migratory capacity, possibly trapping the macrophages in the pancreas and leading to nonspecific damage of ␤-cells (22) . Moreover, thymus and lymph nodes of VDR Ϫ/Ϫ NOD mice contained even fewer mature CD11c ϩ dendritic cells than VDR ϩ/ϩ NOD mice, as reflected by low levels of CD86, proposed to contribute to a defective regulation of diabetogenic T-cells by preventing the full activation of T-cells (23) . Taken together, it is clear that inactivation of VDR intensifies several identified defects in both innate and adaptive immune system of NOD mice-without, however, direct translation in an aggravated disease onset and incidence.
In conclusion, in contrast to vitamin D deficiency, disruption of its receptor, VDR, does not influence the onset, severity, or incidence of insulitis and diabetes in NOD mice of either sex despite the induction of an array of defects in innate and adaptive immune system. Considering this discrepancy in disease phenotype between the ligand-deficient and the receptor-deficient situation, it would be wrong to conclude that no role for vitamin D and its active form, 1,25(OH) 2 D 3 , exists in the prevention of type 1 diabetes or other autoimmune diseases. The link between vitamin D deficiency and a higher prevalence of autoimmune diabetes in genetically high-risk individuals, mice or humans, has clearly been proven. Our present data point toward the interesting observation that nuclear receptors have a function of their own and that having an unliganded receptor present results in a different situation from that of having no receptor present.
